| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.38B | 1.21B | 2.83B | 2.51B | 2.50B |
| Gross Profit | -190.00M | 106.60M | 69.30M | 629.20M | 707.40M |
| EBITDA | 182.80M | 127.90M | 76.80M | -74.70M | 124.10M |
| Net Income | 405.20M | -336.20M | -314.00M | -455.50M | -223.20M |
Balance Sheet | |||||
| Total Assets | 4.28B | 4.16B | 4.43B | 4.81B | 4.38B |
| Cash, Cash Equivalents and Short-Term Investments | 754.40M | 743.40M | 884.80M | 1.33B | 1.47B |
| Total Debt | 2.06B | 1.70B | 1.96B | 1.91B | 1.83B |
| Total Liabilities | 2.72B | 2.99B | 2.92B | 2.88B | 2.67B |
| Stockholders Equity | 1.56B | 1.19B | 1.49B | 1.84B | 1.59B |
Cash Flow | |||||
| Free Cash Flow | 152.50M | -130.50M | -454.20M | -760.40M | -698.00M |
| Operating Cash Flow | 371.20M | 268.90M | 82.20M | 25.50M | -7.30M |
| Investing Cash Flow | -412.20M | -353.70M | -500.10M | -735.00M | -532.70M |
| Financing Cash Flow | 14.80M | -24.30M | -10.10M | 547.10M | 282.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.21B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £1.91B | 17.26 | 12.23% | 0.79% | 7.74% | 30.09% | |
70 Outperform | £7.38B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
66 Neutral | £1.59B | 12.40 | 34.27% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | £1.54B | 3.62 | 24.47% | ― | ― | ― |